Schizophrenia Clinical Trial
Official title:
Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core
Verified date | August 2019 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
The Human Brain Collection Core (HBCC) collects brain and other tissues. They get these from
deceased people who may or may not have had psychiatric disorders. The next of kin gives
permission for researchers to get the tissues. Researchers want to collect medical details of
people whose brains are donated. They also want to use the donated tissue to study brain
chemistry and structure. This could lead to better treatments for mental illness.
Objective:
To create a collection of human brain tissue to learn about the causes and mechanisms of
mental disorders.
Eligibility:
People willing to donate their deceased relative s brain tissue. The deceased person could
not have had any of the following:
Severe mental retardation
Long-lasting seizure disorder
Infections that affect the brain
Decomposition
Brain damage
Being on a respirator for more than 12 hours
Major sepsis
Serious renal or hepatic disease
Certain dementias and degenerative diseases
Design:
Medical Examiner s Offices will screen donors who have recently died. Some others will be
screened by hospitals or funeral homes.
Participants will be the next of kin. They will give consent for HBCC to obtain brain tissue
from the deceased person. The tissue will be frozen for future research.
Participants will have a 30-minute phone call. They will answer questions about the deceased
person s medical and psychiatric conditions. They will answer questions about the person s
use of medicines and drugs.
Participants will be contacted by a social worker. They will be asked for permission to
access the deceased person s medical records.
Status | Terminated |
Enrollment | 192 |
Est. completion date | August 29, 2019 |
Est. primary completion date | August 29, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 120 Years |
Eligibility |
- INCLUSION CRITERIA: Brain tissue is needed from individuals suffering from a variety of neuropsychiatric disorders, including schizophrenia, anxiety disorders, suicide, bipolar disorder, depression, and substance use disorders (cocaine, alcohol, heroin or the like). In addition, brains from individuals without a history of neuropsychiatric disease will be needed as controls. EXCLUSION CRITERIA: An assessment is carried out on the information available from the referral source (generally a Medical Examiner s Office) prior to obtaining consent. This information is usually very succinct, indicating how the decedent was found and, if known, whether they had some psychiatric or obvious medical history. The following cases will be excluded from collection: - Severe mental retardation. - Well documented, long lasting seizure disorder. - Infections known to affect the brain such as syphilis, tuberculosis, with the exception of HIV infection. - The body is decomposed. We consider collecting the brain up to three days after death. - There is obvious damage to the brain by closed head injury or other trauma (gunshot wound, fall, etc.). - There are brain infarcts, hemorrhages, tumors, stroke, or other brain lesions that destroy the normal brain structure. - The patient has been maintained on a respirator (ventilator) for more than 12 hours in the period immediately prior to death. - Major sepsis. - Serious renal or hepatic disease. - Multiple sclerosis (MS), Alzheimer s disease and other dementias and degenerative diseases. - Known infection with Hepatitis C |
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Mental Health (NIMH) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To accumulate a vast repository of human brain tissues and characterize molecular signatures of psychiatric disorders using techniques such as genome-wide association analyses, DNA methylation, acetylation and chromatin modification patterns, RN... | ongoing |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |